Grader variability and the importance of reference standards for evaluating machine learning models for diabetic retinopathy J Krause, V Gulshan, E Rahimy, P Karth, K Widner, GS Corrado, L Peng, ... Ophthalmology 125 (8), 1264-1272, 2018 | 500 | 2018 |
Paracentral acute middle maculopathy: a new variant of acute macular neuroretinopathy associated with retinal capillary ischemia D Sarraf, E Rahimy, AA Fawzi, E Sohn, I Barbazetto, DN Zacks, RA Mittra, ... JAMA ophthalmology 131 (10), 1275-1287, 2013 | 454 | 2013 |
Using a deep learning algorithm and integrated gradients explanation to assist grading for diabetic retinopathy R Sayres, A Taly, E Rahimy, K Blumer, D Coz, N Hammel, J Krause, ... Ophthalmology 126 (4), 552-564, 2019 | 388 | 2019 |
Acute macular neuroretinopathy: a comprehensive review of the literature KV Bhavsar, S Lin, E Rahimy, A Joseph, KB Freund, D Sarraf, ... Survey of ophthalmology 61 (5), 538-565, 2016 | 268 | 2016 |
Spectrum of retinal vascular diseases associated with paracentral acute middle maculopathy X Chen, E Rahimy, RC Sergott, RP Nunes, EC Souza, N Choudhry, ... American journal of ophthalmology 160 (1), 26-34. e1, 2015 | 252 | 2015 |
Paracentral acute middle maculopathy: what we knew then and what we know now E Rahimy, L Kuehlewein, SR Sadda, D Sarraf Retina 35 (10), 1921-1930, 2015 | 202 | 2015 |
The spectrum of superficial and deep capillary ischemia in retinal artery occlusion S Yu, CE Pang, Y Gong, KB Freund, LA Yannuzzi, E Rahimy, BJ Lujan, ... American journal of ophthalmology 159 (1), 53-63. e2, 2015 | 201 | 2015 |
Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management E Rahimy, D Sarraf Survey of ophthalmology 58 (5), 430-458, 2013 | 187 | 2013 |
Assessing deep retinal capillary ischemia in paracentral acute middle maculopathy by optical coherence tomography angiography J Nemiroff, L Kuehlewein, E Rahimy, I Tsui, R Doshi, A Gaudric, MB Gorin, ... American journal of ophthalmology 162, 121-132. e1, 2016 | 172 | 2016 |
Baseline choroidal thickness as a predictor for response to anti–vascular endothelial growth factor therapy in diabetic macular edema N Rayess, E Rahimy, G Ying, N Bagheri, AC Ho, CD Regillo, JF Vander, ... American journal of ophthalmology 159 (1), 85-91. e3, 2015 | 157 | 2015 |
Paracentral acute middle maculopathy in nonischemic central retinal vein occlusion E Rahimy, D Sarraf, ML Dollin, JD Pitcher, AC Ho American Journal of Ophthalmology 158 (2), 372-380. e1, 2014 | 143 | 2014 |
Deep learning applications in ophthalmology E Rahimy Current opinion in ophthalmology 29 (3), 254-260, 2018 | 137 | 2018 |
Paracentral acute middle maculopathy spectral-domain optical coherence tomography feature of deep capillary ischemia E Rahimy, D Sarraf Current Opinion in Ophthalmology 25 (3), 207-212, 2014 | 128 | 2014 |
Robot-assisted intraocular surgery: development of the IRISS and feasibility studies in an animal model E Rahimy, J Wilson, TC Tsao, S Schwartz, JP Hubschman Eye 27 (8), 972-978, 2013 | 127 | 2013 |
Optical coherence tomography angiography and en face optical coherence tomography features of paracentral acute middle maculopathy J Sridhar, A Shahlaee, E Rahimy, BK Hong, MA Khan, JI Maguire, ... American Journal of Ophthalmology 160 (6), 1259-1268. e2, 2015 | 121 | 2015 |
Age-related T-cell cytokine profile parallels corneal disease severity in Sjögren’s syndrome-like keratoconjunctivitis sicca in CD25KO mice CS De Paiva, CS Hwang, JD Pitcher III, SB Pangelinan, E Rahimy, ... Rheumatology 49 (2), 246-258, 2010 | 113 | 2010 |
Postinjection endophthalmitis rates and characteristics following intravitreal bevacizumab, ranibizumab, and aflibercept N Rayess, E Rahimy, P Storey, CP Shah, JD Wolfe, E Chen, FC DeCroos, ... American journal of ophthalmology 165, 88-93, 2016 | 111 | 2016 |
Conversion to aflibercept after prior anti-VEGF therapy for persistent diabetic macular edema E Rahimy, A Shahlaee, MA Khan, G Ying, JI Maguire, AC Ho, CD Regillo, ... American journal of ophthalmology 164, 118-127. e2, 2016 | 96 | 2016 |
Prospective evaluation of the incidence and risk factors for the development of RPE tears after high-and low-dose ranibizumab therapy D Sarraf, C Chan, E Rahimy, P Abraham Retina 33 (8), 1551-1557, 2013 | 92 | 2013 |
A randomized double-blind placebo-control pilot study of eplerenone for the treatment of central serous chorioretinopathy (ecselsior) E Rahimy, JD Pitcher III, J Hsu, MK Adam, A Shahlaee, WA Samara, ... Retina 38 (5), 962-969, 2018 | 85 | 2018 |